Your browser doesn't support javascript.
loading
Inter- and intra-tumor heterogeneity of genetic and immune profiles in inherited renal cell carcinoma.
Tabata, Mariko; Sato, Yusuke; Kogure, Yasunori; McClure, Marni B; Oshikawa-Kumade, Yuji; Saito, Yuki; Shingaki, Sumito; Ito, Yuta; Yuasa, Mitsuhiro; Koya, Junji; Yoshida, Kazushi; Kohno, Takashi; Miyama, Yu; Morikawa, Teppei; Chiba, Kenichi; Okada, Ai; Ogawa, Seishi; Ushiku, Tetsuo; Shiraishi, Yuichi; Kume, Haruki; Kataoka, Keisuke.
Afiliação
  • Tabata M; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo 104-0045, Japan; Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
  • Sato Y; Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan. Electronic address: satoy-uro@h.u-tokyo.ac.jp.
  • Kogure Y; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
  • McClure MB; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
  • Oshikawa-Kumade Y; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo 104-0045, Japan; Diagnostic Division, Otsuka Pharmaceutical Co., Ltd., Tokushima 771-0182, Japan.
  • Saito Y; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo 104-0045, Japan; Department of Gastroenterology, Keio University School of Medicine, Tokyo 160-8582, Japan.
  • Shingaki S; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
  • Ito Y; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo 104-0045, Japan; Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo 105-8471, Japan.
  • Yuasa M; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo 104-0045, Japan; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
  • Koya J; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
  • Yoshida K; Division of Genome Biology, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
  • Kohno T; Division of Genome Biology, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
  • Miyama Y; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
  • Morikawa T; Department of Diagnostic Pathology, NTT Medical Center Tokyo, Tokyo 141-8625, Japan.
  • Chiba K; Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
  • Okada A; Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
  • Ogawa S; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan; Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto 606-8501, Japan; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska
  • Ushiku T; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
  • Shiraishi Y; Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
  • Kume H; Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
  • Kataoka K; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo 104-0045, Japan; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo 160-8582, Japan. Electronic address: kkataoka-tky@umin.ac.jp.
Cell Rep ; 42(7): 112736, 2023 07 25.
Article em En | MEDLINE | ID: mdl-37405915
ABSTRACT
Patients with von Hippel-Lindau disease (vHL) are at risk of developing spatially and temporally multiple clear cell renal cell carcinomas (ccRCCs), which offers a valuable opportunity to analyze inter- and intra-tumor heterogeneity of genetic and immune profiles within the same patient. Here, we perform whole-exome and RNA sequencing, digital gene expression, and immunohistochemical analyses for 81 samples from 51 ccRCCs of 10 patients with vHL. Inherited ccRCCs are clonally independent and have less genomic alterations than sporadic ccRCCs. Hierarchical clustering of transcriptome profiles shows two clusters with distinct immune signatures immune hot and cold clusters. Interestingly, not only samples from the same tumors but also different tumors from the same patients tend to show a similar immune signature, whereas samples from different patients frequently exhibit different signatures. Our findings reveal the genetic and immune landscape of inherited ccRCCs, demonstrating the relevance of host factors in shaping anti-tumor immunity.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma / Carcinoma de Células Renais / Doença de von Hippel-Lindau / Neoplasias Renais Limite: Humans Idioma: En Revista: Cell Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma / Carcinoma de Células Renais / Doença de von Hippel-Lindau / Neoplasias Renais Limite: Humans Idioma: En Revista: Cell Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão